
Epithra 10mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Epirubicin (10mg)
Overview Epithra 10mg Injection
Oncaspar 10mg Injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a qualified healthcare professional via infusion or drip, it requires careful monitoring. This medication may be used alone or in combination chemotherapy regimens, with dosage and frequency determined by your physician based on your condition and subject to change. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, continue treatment unless otherwise instructed. Note that it reduces contraceptive efficacy; reliable contraception is advised for both partners during therapy. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. It can lower blood cell counts, increasing infection risk, potentially life-threatening. Regular blood tests monitoring blood cell counts, renal, hepatic, and cardiac function are crucial during treatment. Prior to commencing treatment, inform your physician of any liver or heart conditions, and of all other medications you are currently using, as interactions can affect efficacy and/or function. Disclose any pregnancy or breastfeeding.
Uses of Epithra 10mg Injection
Malignant neoplasm
Major Benefits of Epithra 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epithra 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epithra 10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Epithra 10mg Injection works:
Epithra 10mg Injection is a cancer treatment that targets breast cancer cells. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within these cells. The drug also generates damaging free radicals, leading to DNA disruption. This dual action impedes breast cancer cell proliferation, ultimately resulting in cell death.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while using Epithra 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epithra 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Epithra 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be compromised by side effects of Epithra 10mg Injection, such as nausea and vomiting. These episodes can temporarily impair driving skills.
KidneySAFE IF PRESCRIBED
Epithra 10mg Injection is likely safe for individuals with kidney impairment. Current evidence indicates dose modification for Epithra 10mg Injection may be unnecessary in such cases. However, physician consultation is recommended. A reduced dosage might be warranted for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should use Epithra 10mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Epithra 10mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epithra 10mg Injection :
NA
Facts to Know About Epithra 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
